Genertec Universal Medical : APPOINTMENT OF A NON-EXECUTIVE DIRECTOR AND CHANGES IN COMPOSITION OF THE AUDIT COMMITTEE

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

GENERTEC UNIVERSAL MEDICAL GROUP COMPANY

LIMITED

通用環球醫療集團有限公司

(Incorporated in Hong Kong with limited liability)

(Stock Code：2666)

APPOINTMENT OF A NON-EXECUTIVE DIRECTOR

AND

CHANGES IN COMPOSITION OF THE AUDIT COMMITTEE

The Board is pleased to announce that with effect from 14 May 2021, Mr. Tong Chaoyin was appointed as a non-executive Director and a member of the Audit Committee.

APPOINTMENT OF A NON-EXECUTIVE DIRECTOR

The board (the "Board") of directors (the "Directors", and each a "Director") of Genertec Universal Medical Group Company Limited (the "Company") is pleased to announce that with effect from 14 May 2021, Mr. Tong Chaoyin (童朝銀) ("Mr. Tong") was appointed as a non- executive Director and a member of the Board's audit committee (the "Audit Committee").

Mr. Tong, aged 56, has extensive experience in corporate governance. He served as a general manager assistant and the board sectary of China General Technology (Group) Holding Company Limited (中國通用技術(集團)控股有限責任公司, "GT-PRC") from February 2010 to August 2019 and December 2018 to March 2021, respectively. From October 2005 to December 2018, Mr.

1

Tong served in several positions in China Xinxing Corporation (Group) (中國新興集團有限責任公

Mr. Tong graduated from Nankai University (南開大學) in July 1986 with a bachelor's degree in law, and graduated from China University of Political Science and Law (中國政法大學) in July 1989 with a master's degree in law. Mr. Tong obtained the certificate of senior economist granted by China Xinxing Corporation (Group) in October 1996, and the qualification of Level-OneIn-house Legal Counsels (企業一級法律顧問) granted by GR-PRC in September 2010.

Mr. Tong and the Company entered into an appointment letter on 14 May 2021, pursuant to which Mr. Tong has been appointed as a non-executive Director since 14 May 2021, and such appointment could be terminated by either Mr. Tong or the Company by giving not less than three months' notice in writing. Mr. Tong will hold office until completion of the next annual general meeting of the Company following his appointment, and will then be eligible for re-election at that general meeting. If Mr. Tong would be re-elected at the Company's next annual general meeting, he will be subject to the requirements under the articles of association of the Company regarding retirement by rotation and re-election at the annual general meeting of the Company. Mr. Tong, pursuant to the appointment letter, is not entitled to any remuneration during his term of service.

As at the date of this announcement, except as disclosed above, Mr. Tong did not (i) have any relationship with any Directors, senior management or substantial or controlling shareholders of the Company; (ii) have any interest in the shares of the Company within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong); (iii) hold any other directorships in public companies the securities of which are listed on any securities market in Hong Kong or overseas in the last three years; and (iv) hold other positions with the Company or its subsidiaries.

Save as disclosed above, to the best of the knowledge, information and belief of the Directors after having made all reasonable enquiries, there is no information in relation to the appointment of Mr. Tong that is required to be disclosed pursuant to Rule 13.51(2)(h) to (v) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and there is no other matter that

2

needs to be brought to the attention of the shareholders of the Company.

The Board would like to extend its warm welcome to Mr. Tong's role as a non-executive Director.

CHANGE IN COMPOSITION OF THE AUDIT COMMITTEE

The Board would like to announce that with effect from 14 May 2021, Mr. Tong was appointed as a member of the Audit Committee. The Audit Committee comprises the following Directors:

• Mr. Li Yinquan (chairman of the committee and independent non-executive Director)
• Mr. Chow Siu Lui (independent non-executive Director)
• Mr. Tong Chaoyin (non-executive Director)

By order of the Board

Genertec Universal Medical Group Company

Limited

通用環球醫療集團有限公司

Peng Jiahong

Executive Director

Beijing, PRC, 14 May 2021

As at the date of this announcement, the executive Directors are Ms. Peng Jiahong (Vice- chairwoman) and Mr. Yu Gang; the non-executive Directors are Mr. Zhang Yichen (Chairman), Mr. Tong Chaoyin, Ms. Liu Kun and Mr. Liu Zhiyong; and the independent non-executive Directors are Mr. Li Yinquan, Mr. Chow Siu Lui, Mr. Han Demin and Mr. Liao Xinbo.

3